{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T05:59:08Z","timestamp":1774159148770,"version":"3.50.1"},"reference-count":170,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH\/NIDDK","award":["R35GM147094"],"award-info":[{"award-number":["R35GM147094"]}]},{"name":"NIH\/NIDDK","award":["R21DK130015"],"award-info":[{"award-number":["R21DK130015"]}]},{"name":"University of Texas System STARS program"},{"DOI":"10.13039\/100001447","name":"Rita Allen Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001447","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The crosstalk between the endocannabinoid system (ECS) and reactive nitrogen species (RNS) has emerged as an important area of investigation in recent years. Although many aspects of this interaction remain elusive, accumulating evidence demonstrates that the ECS plays a critical role in regulating RNS-mediated signaling under physiological conditions. This modulation can be either inhibitory or stimulatory, depending on the specific receptor subtype, cell type, and tissue location involved. While ECS-RNS interactions support normal cellular homeostasis, their dysregulation contributes to various disease states, particularly neurodegenerative disorders. Studies in both rodent models and human subjects show that ECS modulation can reduce anxiety, attenuate neuroinflammatory responses, and slow disease progression in neurodegenerative conditions. This review examines how cannabinoid-based interventions modulate nitrosative stress and neuroinflammation in Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD), highlighting their potential as targeted therapeutics that address multiple pathological mechanisms simultaneously and may offer advantages over conventional treatment approaches.<\/jats:p>","DOI":"10.3390\/ijms27062813","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:44:41Z","timestamp":1773999881000},"page":"2813","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radical Revelations: The Interplay of Nitrosative Stress, the Endocannabinoid System, and Treatment of Age-Related Disorders"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6481-716X","authenticated-orcid":false,"given":"Avery","family":"Davis","sequence":"first","affiliation":[{"name":"Neuroimmunology and Behavior Lab (NIB), Department of Neuroscience, School of Behavioral and Brain Science, Center for Advanced Pain Studies (CAPS), University of Texas at Dallas, Richardson, TX 75080, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella Y.","family":"Casmedes","sequence":"additional","affiliation":[{"name":"Neuroimmunology and Behavior Lab (NIB), Department of Neuroscience, School of Behavioral and Brain Science, Center for Advanced Pain Studies (CAPS), University of Texas at Dallas, Richardson, TX 75080, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0628-824X","authenticated-orcid":false,"given":"Michael D.","family":"Burton","sequence":"additional","affiliation":[{"name":"Neuroimmunology and Behavior Lab (NIB), Department of Neuroscience, School of Behavioral and Brain Science, Center for Advanced Pain Studies (CAPS), University of Texas at Dallas, Richardson, TX 75080, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An Introduction to the Endogenous Cannabinoid System","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lawley, S., Green, A., Johnson, C., and Burton, M.D. (2025). Interspecies differences in the expression of cannabinoid receptors at the tissue and cellular levels. Neural Regen. Res.","DOI":"10.4103\/NRR.NRR-D-25-00806"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1098\/rstb.2012.0313","article-title":"Endocannabinoids in nervous system health and disease: The big picture in a nutshell","volume":"367","author":"Skaper","year":"2012","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"116507","DOI":"10.1016\/j.bmc.2021.116507","article-title":"Further Exploration of the Structure-Activity Relationship of Dual Soluble Epoxide Hydrolase\/Fatty Acid Amide Hydrolase Inhibitors","volume":"51","author":"Wilt","year":"2021","journal-title":"Bioorganic Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e00682","DOI":"10.1002\/prp2.682","article-title":"Diversity of molecular targets and signaling pathways for CBD","volume":"8","author":"Almeida","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Leo, L.M., and Abood, M.E. (2021). CB1 Cannabinoid Receptor Signaling and Biased Signaling. Molecules, 26.","DOI":"10.3390\/molecules26175413"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Zou, S., and Kumar, U. (2018). Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030833"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"177612","DOI":"10.1016\/j.ejphar.2025.177612","article-title":"Cannabinoid agonist WIN55,212-2 prevents scopolamine-induced impairment of spatial memory in rats","volume":"998","author":"Tena","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1074\/jbc.M306642200","article-title":"Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners *","volume":"279","author":"Okamoto","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101194","DOI":"10.1016\/j.plipres.2022.101194","article-title":"Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities","volume":"89","author":"Mock","year":"2023","journal-title":"Prog. Lipid Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/bph.12411","article-title":"Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS","volume":"171","author":"Murataeva","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/biof.131","article-title":"Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol","volume":"37","author":"Ueda","year":"2011","journal-title":"BioFactors"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0896-6273(01)00247-1","article-title":"Endogenous Cannabinoids Mediate Retrograde Signals from Depolarized Postsynaptic Neurons to Presynaptic Terminals","volume":"29","author":"Maejima","year":"2001","journal-title":"Neuron"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/15504263.2019.1668100","article-title":"Cannabinoid Receptor type 1 and its role as an analgesic: An opioid alternative?","volume":"16","author":"Milligan","year":"2019","journal-title":"J. Dual Diagn."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100213","DOI":"10.1016\/j.clinsp.2023.100213","article-title":"A-80426 suppresses CFA-induced inflammatory pain by suppressing TRPV1 activity via NF\u03baB and PI3K pathways in mice","volume":"78","author":"Ling","year":"2023","journal-title":"Clinics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1021\/acsmedchemlett.8b00618","article-title":"TRPV1 Modulators for the Treatment of Pain and Inflammation","volume":"10","author":"Kargbo","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"150276","DOI":"10.1098\/rsob.150276","article-title":"Modulation of cellular redox homeostasis by the endocannabinoid system","volume":"6","author":"Lipina","year":"2016","journal-title":"Open Biol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Shan, R., Zhang, Y., Shi, Y., Wang, X., Wang, X., Ma, G., and Li, Q. (2024). Activation of Cannabinoid Type 2 Receptor in Microglia Reduces Neuroinflammation through Inhibiting Aerobic Glycolysis to Relieve Hypertension. Biomolecules, 14.","DOI":"10.3390\/biom14030333"},{"key":"ref_19","first-page":"805","article-title":"Trp Channels in Disease","volume":"1772","author":"Jordt","year":"2007","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.neuron.2024.02.016","article-title":"TRPV1 analgesics disturb core body temperature via a biased allosteric mechanism involving conformations distinct from that for nociception","volume":"112","author":"Huang","year":"2024","journal-title":"Neuron"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0031-6997(24)01403-0","article-title":"Vanilloid (Capsaicin) Receptors and Mechanisms","volume":"51","author":"Szallasi","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e70099","DOI":"10.1111\/cns.70099","article-title":"CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate-Induced Excitotoxicity Through a Reduction of NOX-2 Activity and Oxidative Stress","volume":"30","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40263-015-0270-y","article-title":"Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer\u2019s Disease","volume":"29","author":"Liu","year":"2015","journal-title":"CNS Drugs"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jagp.2019.05.002","article-title":"Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer\u2019s Disease","volume":"27","author":"Herrmann","year":"2019","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Marsicano, G., and Kuner, R. (2008). Anatomical Distribution of Receptors, Ligands and Enzymes in the Brain. Cannabinoids and the Brain, Springer.","DOI":"10.1007\/978-0-387-74349-3_10"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/s41467-023-37864-4","article-title":"Structural basis for activation of CB1 by an endocannabinoid analog","volume":"14","author":"Kumar","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/ACO.0000000000000616","article-title":"An overview of the cannabinoid type 2 (CB2) receptor system and its therapeutic potential","volume":"31","author":"Bie","year":"2018","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e175205","DOI":"10.1172\/JCI175205","article-title":"Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft-versus-host disease","volume":"134","author":"Moe","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/s42255-025-01388-6","article-title":"Mitochondrial and psychosocial stress-related regulation of FGF21 in humans","volume":"7","author":"Kurade","year":"2025","journal-title":"Nat. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"30610","DOI":"10.1038\/srep30610","article-title":"The Spectrum of Mitochondrial Ultrastructural Defects in Mitochondrial Myopathy","volume":"6","author":"Vincent","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.celrep.2019.01.010","article-title":"Quantitative 3D Mapping of the Human Skeletal Muscle Mitochondrial Network","volume":"26","author":"Vincent","year":"2019","journal-title":"Cell Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41586-025-08740-6","article-title":"A human brain map of mitochondrial respiratory capacity and diversity","volume":"641","author":"Mosharov","year":"2025","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tibs.2024.01.011","article-title":"Mitochondria in disease: Changes in shapes and dynamics","volume":"49","author":"Jenkins","year":"2024","journal-title":"Trends Biochem. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e14009","DOI":"10.1111\/acel.14009","article-title":"3D reconstruction of murine mitochondria reveals changes in structure during aging linked to the MICOS complex","volume":"22","author":"Vue","year":"2023","journal-title":"Aging Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"109509","DOI":"10.1016\/j.celrep.2021.109509","article-title":"3D neuronal mitochondrial morphology in axons, dendrites, and somata of the aging mouse hippocampus","volume":"36","author":"Faitg","year":"2021","journal-title":"Cell Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1089\/ars.2007.1993","article-title":"Reactive nitrogen species: Molecular mechanisms and potential significance in health and disease","volume":"11","author":"Andriantsitohaina","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41420-024-02278-8","article-title":"Free radicals and their impact on health and antioxidant defenses: A review","volume":"11","author":"Chandimali","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1523\/JNEUROSCI.23-05-01941.2003","article-title":"On the Role of Nitric Oxide in Hippocampal Long-Term Potentiation","volume":"23","author":"Bon","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"109515","DOI":"10.1016\/j.isci.2024.109515","article-title":"Anoxia-induced hippocampal LTP is regeneratively produced by glutamate and nitric oxide from the neuro-glial-endothelial axis","volume":"27","author":"Wang","year":"2024","journal-title":"iScience"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0006-291X(91)91279-L","article-title":"Phosphorylation of nitric oxide synthase by protein kinase A","volume":"181","author":"Lapetina","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/ars.2023.0395","article-title":"Increased Neuronal Nitric Oxide Synthase in Alzheimer\u2019s Disease Mediates Spontaneous Calcium Signaling and Divergent Glutamatergic Calcium Responses","volume":"41","author":"Balez","year":"2024","journal-title":"Antioxid. Redox Signal."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.apsb.2024.10.004","article-title":"Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications","volume":"15","author":"Dash","year":"2024","journal-title":"Acta Pharm. Sinica. B"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e12455","DOI":"10.1002\/jev2.12455","article-title":"Microglial activation induces nitric oxide signalling and alters protein S-nitrosylation patterns in extracellular vesicles","volume":"13","author":"Vassileff","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"ref_46","unstructured":"Gruber, S. (2025). Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults with Mild Cognitive Impairment or Alzheimers Dementia (AD), National Library of Medicine."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.beem.2012.05.003","article-title":"Cellular and molecular mechanisms of mitochondrial function","volume":"26","author":"Osellame","year":"2012","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_48","first-page":"3","article-title":"Mitochondrial electron transport chain, ROS generation and uncoupling (Review)","volume":"44","author":"Zhao","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/CIRCRESAHA.118.310082","article-title":"Calcium Signaling and Reactive Oxygen Species in Mitochondria","volume":"122","author":"Bertero","year":"2018","journal-title":"Circ. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ceca.2019.02.006","article-title":"Redox regulation of ER and mitochondrial Ca2+ signaling in cell survival and death","volume":"79","author":"Joseph","year":"2019","journal-title":"Cell Calcium"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Mattila, J.T., and Thomas, A.C. (2014). Nitric oxide synthase: Non-canonical expression patterns. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00478"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1089\/ars.2006.8.929","article-title":"Regulation of Inducible Nitric Oxide Synthase Gene in Glial Cells","volume":"8","author":"Saha","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez, J., Guano, A.D., Mazzitelli, I., Dennis, V.A., Rodr\u00edguez, A.M., and Giambartolomei, G.H. (2025). Frontiers | Type I interferons regulate nitric oxide production in Brucella abortus-activated microglia contributing to neuronal death. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1661395"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0014-2999(93)90873-G","article-title":"Inhibitory action of N\u03c9-nitro-L-arginine methyl ester on in vivo long-term potentiation in the rat dentate gyrus","volume":"238","author":"Iga","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1523\/JNEUROSCI.2259-06.2006","article-title":"Tonic and Phasic Nitric Oxide Signals in Hippocampal Long-Term Potentiation","volume":"26","author":"Hopper","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0006-291X(05)81351-8","article-title":"Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase","volume":"180","author":"Nakane","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.febslet.2004.05.083","article-title":"Calcium\/calmodulin-dependent protein kinase I inhibits neuronal nitric-oxide synthase activity through serine 741 phosphorylation","volume":"570","author":"Song","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.274.20.13729","article-title":"Cyclic GMP Phosphodiesterase-5: Target of Sildenafil *","volume":"274","author":"Corbin","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"P\u0142oska, A., Siekierzycka, A., Cie\u015blik, P., Dobrucki, L.W., Kalinowski, L., and Wiero\u0144ska, J.M. (2024). The Impact of LY487379 or CDPPB on eNOS Expression in the Mouse Brain and the Effect of Joint Administration of Compounds with NO\u2022 Releasers on MK-801- or Scopolamine-Driven Cognitive Dysfunction in Mice. Molecules, 29.","DOI":"10.3390\/molecules29030627"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuropharm.2007.06.027","article-title":"Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells","volume":"54","author":"Jones","year":"2007","journal-title":"Neuropharmacology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11481-009-9153-7","article-title":"Cannabinoid Regulation of Nitric Oxide Synthase I (nNOS) in Neuronal Cells","volume":"4","author":"Carney","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/mol.65.3.665","article-title":"Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons","volume":"65","author":"Guo","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/bph.16035","article-title":"BPS Publications","volume":"180","author":"Harding","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/bj3220167","article-title":"Pathways of peroxynitrite oxidation of thiol groups","volume":"322","author":"Quijano","year":"1997","journal-title":"Biochem. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/bj2900051","article-title":"Peroxynitrite-induced luminol chemiluminescence","volume":"290","author":"Radi","year":"1993","journal-title":"Biochem. J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00395-014-0433-x","article-title":"S-nitrosation of mitochondrial connexin 43 regulates mitochondrial function","volume":"109","author":"Soetkamp","year":"2014","journal-title":"Basic Res. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"28849","DOI":"10.18632\/oncotarget.6680","article-title":"The histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells","volume":"7","author":"Campanella","year":"2015","journal-title":"Oncotarget"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"19055","DOI":"10.1074\/jbc.M115.663278","article-title":"Nitration of Hsp90 on Tyrosine 33 Regulates Mitochondrial Metabolism","volume":"290","author":"Franco","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Bavisotto, C.C., Alberti, G., Vitale, A.M., Paladino, L., Campanella, C., Rappa, F., Gorska, M., Macario, E.C.d., Cappello, F., and Macario, A.J.L. (2020). Hsp60 Post-translational Modifications: Functional and Pathological Consequences. Front. Mol. Biosci., 7.","DOI":"10.3389\/fmolb.2020.00095"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1042\/BCJ20253230","article-title":"Nitration-driven structural changes in Hsp90 linked to gain of pathological functions","volume":"482","author":"Chatterjee","year":"2025","journal-title":"Biochem. J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainres.2015.06.021","article-title":"Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hippocampus","volume":"1622","author":"Zou","year":"2015","journal-title":"Brain Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jmcb\/mjx008","article-title":"The endocannabinoid system: \u2018NO\u2019 longer anonymous in the control of nitrergic signalling?","volume":"9","author":"Lipina","year":"2017","journal-title":"J. Mol. Cell Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/glia.23738","article-title":"Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS\/NF-\u03baB-dependent signaling and glucose consumption","volume":"68","author":"Michel","year":"2020","journal-title":"Glia"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1124\/jpet.104.079509","article-title":"Involvement of Protein Kinase A in Cannabinoid Receptor-Mediated Protection from Oxidative Neuronal Injury","volume":"313","author":"Kim","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jnr.10165","article-title":"Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures","volume":"67","author":"Guaza","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1073\/pnas.0604056103","article-title":"Antioxidants reduce cone cell death in a model of retinitis pigmentosa","volume":"103","author":"Komeima","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Piano, I., Corsi, F., Polini, B., and Gargini, C. (2022). Frontiers | Nutraceutical Molecules Slow Down Retinal Degeneration, in Tvrm4 Mice a Model of Retinitis Pigmentosa, by Genetic Modulation of Anti-oxidant Pathway. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.868750"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Kasatkina, L.A., Rittchen, S., and Sturm, E.M. (2021). Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115431"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbrc.2015.01.073","article-title":"Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling","volume":"458","author":"Ma","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neuropharm.2014.06.006","article-title":"The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury","volume":"85","author":"Tchantchou","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.neulet.2006.06.012","article-title":"CB1 receptor selective activation inhibits \u03b2-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons","volume":"404","author":"Esposito","year":"2006","journal-title":"Neurosci. Lett."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Aguirre-Rueda, D., Guerra-Ojeda, S., Aldasoro, M., Iradi, A., Obrador, E., Mauricio, M.D., Vila, J.M., Marchio, P., and Valles, S.L. (2015). WIN 55,212-2, Agonist of Cannabinoid Receptors, Prevents Amyloid \u03b21-42 Effects on Astrocytes in Primary Culture. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122843"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s10194-025-02261-3","article-title":"Macrophages and iNOS contribute to the effects of dural prolactin and repeated stress in mouse migraine models","volume":"27","author":"Mei","year":"2025","journal-title":"J. Headache Pain"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3892\/mmr.2023.13004","article-title":"MAGL regulates synovial macrophage polarization vis inhibition of mitophagy in osteoarthritic pain","volume":"27","author":"Gu","year":"2023","journal-title":"Mol. Med. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bcp.2018.08.007","article-title":"Genetic deletion of CB1 cannabinoid receptors exacerbates the Alzheimer-like symptoms in a transgenic animal model","volume":"157","author":"Aso","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"118818","DOI":"10.1016\/j.biopha.2025.118818","article-title":"CB1 receptor activation and inhibition differentially modulate cognitive deficits and neuropathology in 3xTg-AD mice","volume":"193","author":"Ye","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"117401","DOI":"10.1016\/j.bcp.2025.117401","article-title":"Synaptic scaffold protein PSD-95: A therapeutic target for Alzheimer\u2019s disease","volume":"242","author":"Fan","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/mp.2017.246","article-title":"Markers of microglia in post-mortem brain samples from patients with Alzheimer\u2019s disease: A systematic review","volume":"23","author":"Hopperton","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Kecheliev, V., Spinelli, F., Herde, A., Haider, A., Mu, L., Klohs, J., Ametamey, S.M., and Ni, R. (2022). Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer\u2019s disease. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.1018610"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer\u2019s Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation","volume":"25","author":"Pulgar","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/glia.24312","article-title":"Altered glial expression of the cannabinoid 1 receptor in the subiculum of a mouse model of Alzheimer\u2019s disease","volume":"71","author":"Terradillos","year":"2023","journal-title":"Glia"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer\u2019s Disease Brains","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1111\/febs.17403","article-title":"Fatty-acid amide hydrolase inhibition mitigates Alzheimer\u2019s disease progression in mouse models of amyloidosis","volume":"292","author":"Oddi","year":"2025","journal-title":"Febs J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/18756190MTA2pMjApy","article-title":"Role of Nitric Oxide in Neurodegeneration: Function, Regulation, and Inhibition","volume":"19","author":"Tewari","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pharmthera.2005.05.007","article-title":"Role of nitric oxide in Parkinson\u2019s disease","volume":"109","author":"Zhang","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Strekalova, T., Burova, A., Gorlova, A., Chaprov, K., Khizeva, A., Coelho, J.E., Svirin, E., Novikova, P., Ohanyan, L., and Munter, J.J.M.P.d. (2025). Bolus MPTP Injection in Aged Mice to Mimic Parkinson Disease: Effects of Low-Dose Antioxidant Treatment with Fullerene (C60) and Fullerenol (C60(OH)24). Biomedicines, 13.","DOI":"10.3390\/biomedicines13102425"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1474-4422(02)00102-3","article-title":"The role of nitric oxide in multiple sclerosis","volume":"1","author":"Smith","year":"2002","journal-title":"Lancet Neurol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.niox.2024.01.006","article-title":"Nitric oxide involvement in the disability and active disease of multiple sclerosis: Systematic review and meta-analysis","volume":"145","author":"Silva","year":"2024","journal-title":"Nitric Oxide"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1523\/JNEUROSCI.0294-06.2006","article-title":"Neuronal Nitric Oxide Synthase Plays a Key Role in CNS Demyelination","volume":"26","author":"Taconis","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.niox.2025.09.003","article-title":"7-Nitroindazole, an nNOS inhibitor, reduces migraine-like nociception, demyelination, and anxiety-like behavior in a mouse model of relapsing-remitting multiple sclerosis","volume":"159","author":"Silva","year":"2025","journal-title":"Nitric Oxide"},{"key":"ref_101","first-page":"1279042","article-title":"Marijuana Compounds: A Nonconventional Approach to Parkinson\u2019s Disease Therapy","volume":"2016","author":"Babayeva","year":"2016","journal-title":"Park. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/WNF.0000000000000246","article-title":"Medical Cannabis in Parkinson Disease: Real-Life Patients\u2019 Experience","volume":"40","author":"Balash","year":"2017","journal-title":"Clin. Neuropharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/WNF.0000000000000016","article-title":"Cannabis (Medical Marijuana) Treatment for Motor and Non\u2013Motor Symptoms of Parkinson Disease: An Open-Label Observational Study","volume":"37","author":"Lotan","year":"2014","journal-title":"Clin. Neuropharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1476-5381.2011.01278.x","article-title":"Symptom-relieving and neuroprotective effects of the phytocannabinoid \u03949-THCV in animal models of Parkinson\u2019s disease","volume":"163","author":"Ramos","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"104892","DOI":"10.1016\/j.nbd.2020.104892","article-title":"Beneficial effects of the phytocannabinoid \u03949-THCV in L-DOPA-induced dyskinesia in Parkinson\u2019s disease","volume":"141","author":"Espadas","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.expneurol.2015.07.024","article-title":"Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease","volume":"273","author":"Mounsey","year":"2015","journal-title":"Exp. Neurol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"108394","DOI":"10.1016\/j.pharmthera.2023.108394","article-title":"Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases","volume":"244","author":"Chen","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1111\/bph.15185","article-title":"A systematic review of minor phytocannabinoids with promising neuroprotective potential","volume":"177","author":"Stone","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Giuliano, C., Francavilla, M., Ongari, G., Petese, A., Ghezzi, C., Rossini, N., Blandini, F., and Cerri, S. (2021). Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168920"},{"key":"ref_110","first-page":"413S","article-title":"ACCP Journals","volume":"21","author":"Petro","year":"1981","journal-title":"J. Clin. Pharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1300\/J251v07n01_04","article-title":"Delta-9-THC in the treatment of spasticity associated with multiple sclerosis","volume":"7","author":"Ungerleider","year":"1987","journal-title":"Adv. Alcohol Subst. Abus."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2147\/TCRM.S115014","article-title":"An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland who have been prescribed Sativex\u00ae (THC:CBD, nabiximols) oromucosal spray","volume":"12","author":"Etges","year":"2016","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/jnnp.2005.070136","article-title":"Cannabinoids in multiple sclerosis (CAMS) study: Safety and efficacy data for 12 months follow up","volume":"76","author":"Zajicek","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Haddad, F., Dokmak, G., and Karaman, R. (2022). The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms. Life, 12.","DOI":"10.3390\/life12050682"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(03)14738-1","article-title":"Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): Multicentre randomised placebo-controlled trial","volume":"362","author":"Zajicek","year":"2003","journal-title":"Lancet"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00415-006-0218-8","article-title":"Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain","volume":"253","author":"Wissel","year":"2006","journal-title":"J. Neurol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e8826","DOI":"10.1097\/MD.0000000000008826","article-title":"The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis: Rationale, study design, and methodology","volume":"96","author":"Russo","year":"2017","journal-title":"Medicine"},{"key":"ref_118","unstructured":"The American Parkinson Disease Association (APDA) (2024, August 27). Medical Marijuana and Parkinson\u2019s Disease. Available online: https:\/\/www.apdaparkinson.org\/living-with-parkinsons-disease\/treatment-medication\/medical-marijuana-and-parkinsons-disease\/."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"656582","DOI":"10.1155\/2015\/656582","article-title":"Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation","volume":"2015","author":"Russo","year":"2015","journal-title":"Neural Plast."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Gargano, A., Beins, E., Zimmer, A., and Bilkei-Gorzo, A. (2020). Lack of Cannabinoid Receptor Type-1 Leads to Enhanced Age-Related Neuronal Loss in the Locus Coeruleus. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010005"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.brainresbull.2021.06.022","article-title":"The role of endocannabinoid pathway in the neuropathology of Alzheimer\u2019s disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer\u2019s disease?","volume":"174","author":"Bajaj","year":"2021","journal-title":"Brain Res. Bull."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1007\/s12035-021-02400-2","article-title":"Inhibition of 2-arachidonoylglycerol metabolism alleviates neuropathology and improves cognitive function in a tau mouse model of Alzheimer\u2019s disease","volume":"58","author":"Hashem","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00018-006-6037-3","article-title":"Endocannabinoids and \u03b2-amyloid-induced neurotoxicity in vivo: Effect of pharmacological elevation of endocannabinoid levels","volume":"63","author":"Stelt","year":"2006","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/jpet.110.169946","article-title":"Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1\/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice","volume":"334","author":"Cluny","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(98)01283-1","article-title":"Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action","volume":"21","author":"Melck","year":"1998","journal-title":"Trends Neurosci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nm.4311","article-title":"A chronic low dose of \u03949-tetrahydrocannabinol (THC) restores cognitive function in old mice","volume":"23","author":"Albayram","year":"2017","journal-title":"Nat. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: Procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat. Protoc."},{"key":"ref_129","first-page":"e55718","article-title":"Novel Object Recognition Test for the Investigation of Learning and Memory in Mice","volume":"2017","author":"Lueptow","year":"2017","journal-title":"J. Vis. Exp. JoVE"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/s41598-024-52277-z","article-title":"A systematic review and meta-analysis of how social memory is studied","volume":"14","author":"Cum","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbr.2008.02.009","article-title":"A new test paradigm for social recognition evidenced by urinary scent marking behavior in C57BL\/6J mice","volume":"190","author":"Arakawa","year":"2008","journal-title":"Behav. Brain Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ntt.2006.05.003","article-title":"A social recognition test for female mice reveals behavioral effects of developmental chlorpyrifos exposure","volume":"28","author":"A","year":"2006","journal-title":"Neurotoxicol. Teratol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"pyv005","DOI":"10.1093\/ijnp\/pyv005","article-title":"Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System","volume":"18","author":"Lisboa","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"20160206","DOI":"10.1098\/rstb.2016.0206","article-title":"Freeze for action: Neurobiological mechanisms in animal and human freezing","volume":"372","author":"Roelofs","year":"2017","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.neuron.2010.07.008","article-title":"A neural switch for active and passive fear","volume":"67","author":"Gozzi","year":"2010","journal-title":"Neuron"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tics.2019.12.016","article-title":"Space, Time, and Fear: Survival Computations along Defensive Circuits","volume":"24","author":"Mobbs","year":"2020","journal-title":"Trends Cogn. Sci."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1152\/physiolgenomics.00006.2019","article-title":"Medial prefrontal cortex in neurological diseases","volume":"51","author":"Xu","year":"2019","journal-title":"Physiol. Genom."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.neuron.2012.12.002","article-title":"The Role of Medial Prefrontal Cortex in Memory and Decision Making","volume":"76","author":"Euston","year":"2012","journal-title":"Neuron"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.neuro.24.1.167","article-title":"An integrative theory of prefrontal cortex function","volume":"24","author":"Miller","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1460-9568.2007.05476.x","article-title":"Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission","volume":"25","author":"Haller","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"107965","DOI":"10.1016\/j.neuropharm.2020.107965","article-title":"Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder","volume":"166","author":"Vimalanathan","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/npp.2017.305","article-title":"Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats","volume":"43","author":"Morena","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1191\/1352458504ms1009oa","article-title":"Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte\/endothelial interactions in an experimental autoimmune encephalomyelitis model","volume":"10","author":"Ni","year":"2004","journal-title":"Mult. Scler."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(96)13308-5","article-title":"The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain","volume":"221","author":"Herzberg","year":"1997","journal-title":"Neurosci. Lett."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/epi.14629","article-title":"Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models","volume":"60","author":"Patra","year":"2018","journal-title":"Epilepsia"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.brainresbull.2021.06.017","article-title":"Cannabidiol in the prelimbic cortex modulates the comorbid condition between the chronic neuropathic pain and depression-like behaviour in rats: The role of medial prefrontal cortex 5-HT1A and CB1 receptors","volume":"174","author":"Malvestio","year":"2021","journal-title":"Brain Res. Bull."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Vera, G., L\u00f3pez-G\u00f3mez, L., Gir\u00f3n, R., Mart\u00edn-Fontelles, M.I., Nurgali, K., Abalo, R., and Uranga, J.A. (2023). Effect of the Cannabinoid Agonist WIN 55,212-2 on Neuropathic and Visceral Pain Induced by a Non-Diarrheagenic Dose of the Antitumoral Drug 5-Fluorouracil in the Rat. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914430"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.108.147181","article-title":"Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative\/Nitrosative Stress, Inflammation, and Cell Death","volume":"328","author":"Pan","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1161\/STROKEAHA.118.023587","article-title":"Cannabis and cannabinoid biology in stroke: Controversies, risks, and promises","volume":"50","author":"Choi","year":"2019","journal-title":"Stroke"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11481-025-10171-z","article-title":"The Effects of Cannabinoids on Ischemic Stroke-Associated Neuroinflammation: A Systematic Review","volume":"20","author":"Alraddadi","year":"2025","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_152","unstructured":"University of Colorado, Denver (2024). CBD for Individuals at Risk of Alzheimer\u2019s Disease, University of Colorado, Denver."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Hermush, V., Ore, L., Stern, N., Mizrahi, N., Fried, M., Krivoshey, M., Staghon, E., Lederman, V.E., and Schleider, L.B.-L. (2022). Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: A placebo controlled randomized clinical trial. Front. Med., 9.","DOI":"10.3389\/fmed.2022.951889"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/sj.bjp.0705896","article-title":"Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors","volume":"142","author":"Akerman","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.38149.566979.AE","article-title":"Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial","volume":"329","author":"Svendsen","year":"2004","journal-title":"BMJ Br. Med. J."},{"key":"ref_156","first-page":"49","article-title":"Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics","volume":"8","author":"May","year":"2016","journal-title":"Cancer Manag. Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0885-3924(94)00117-4","article-title":"Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS","volume":"10","author":"Beal","year":"1995","journal-title":"J. Pain Symptom Manag."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/s41386-025-02213-0","article-title":"Cannabidiol prevents cognitive and social deficits in a male rat model of Alzheimer\u2019s disease through CB1 activation and inflammation modulation","volume":"50","author":"Toledano","year":"2025","journal-title":"Neuropsychopharmacology"},{"key":"ref_159","first-page":"8825358","article-title":"Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review","volume":"2023","author":"Singh","year":"2023","journal-title":"Behav. Neurol."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Goodland, M.N., Banerjee, S., Niehoff, M.L., Young, B.J., Macarthur, H., Butler, A.A., Morley, J.E., and Farr, S.A. (2025). Cannabidiol improves learning and memory deficits and alleviates anxiety in 12-month-old SAMP8 mice. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0296586"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"100385","DOI":"10.1016\/j.conctc.2019.100385","article-title":"Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer\u2019s disease: Study protocol for a cross-over randomized controlled trial","volume":"15","author":"Ruthirakuhan","year":"2019","journal-title":"Contemp. Clin. Trials Commun."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.0.CO;2-D","article-title":"Effects of Dronabinol on anorexia and disturbed behavior in patients with Alzheimer\u2019s disease","volume":"12","author":"Volicer","year":"1997","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"pyv092","DOI":"10.1093\/ijnp\/pyv092","article-title":"The CB1 Neutral Antagonist Tetrahydrocannabivarin Reduces Default Mode Network and Increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers","volume":"19","author":"Rzepa","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Bietar, B., Tanner, S., and Lehmann, C. (2023). Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242316728"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Ruehle, S., Rey, A.A., Remmers, F., and Lutz, B. (2012). The endocannabinoid system in anxiety, fear memory and habituation. J. Psychopharmacol., 26.","DOI":"10.1177\/0269881111408958"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Miculas, D.C., Negru, P.A., Bungau, S.G., Behl, T., Hassan, S.S.U., and Tit, D.M. (2022). Pharmacotherapy Evolution in Alzheimer\u2019s Disease: Current Framework and Relevant Directions. Cells, 12.","DOI":"10.3390\/cells12010131"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s44319-024-00294-4","article-title":"The controversy around anti-amyloid antibodies for treating Alzheimer\u2019s disease: The European Medical Agency\u2019s ruling against the latest anti-amyloid drugs highlights the ongoing debate about their safety and efficacy","volume":"25","author":"Hunter","year":"2024","journal-title":"EMBO Rep."},{"key":"ref_168","first-page":"37","article-title":"Side effects of a dopamine agonist therapy for Parkinson\u2019s disease: A mini review of clinical pharmacology","volume":"89","author":"Borovac","year":"2016","journal-title":"Embo Rep."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson\u2019s disease who were treated with ropinirole or levodopa","volume":"342","author":"Rascol","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"175884","DOI":"10.1016\/j.ejphar.2023.175884","article-title":"Dopamine agonists versus levodopa monotherapy in early Parkinson\u2019s disease for the potential risks of motor complications: A network meta-analysis","volume":"954","author":"Zhang","year":"2023","journal-title":"Eur. J. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/6\/2813\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T05:13:43Z","timestamp":1774156423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/6\/2813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":170,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ijms27062813"],"URL":"https:\/\/doi.org\/10.3390\/ijms27062813","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}